Atlas Trials

UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus

Clinical trial NCT02192775 · COMPLETED

Trial details

NCT number
NCT02192775
Sponsor
University of Arkansas
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2015-03-01
Primary completion
2019-08-20
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.